Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
cleavage sites pH-dependent stability profiles (pH 1.5-8.0) Temperature stability assessment Oxidative and hydrolytic degradation pathways Stabilization Technology Research: Protease inhibitor effectiveness in protecting oral peptides Mucoadhesive polymer effects on gastric residence time Cyclodextrin complexation for stability enhancement PEGylation and chemical modification effects on oral bioavailability Laboratory Handling and Administration Protocols Capsule Storage: Store at room temperature (15-30C) in sealed container Protect from moisture using desiccant packets Keep away from direct light exposure Stable for extended periods at room temperature (exceptional for peptides) No refrigeration required (unlike most peptide formulations) Oral Administration in Research Models: Rodent Models: Oral gavage administration using appropriate gavage needles Capsule can be opened and contents suspended in water or vehicle Typical volumes: 0.2-0.5 mL per mouse, 1-2 mL per rat Fed vs
Factors that may contribute to interstitial cystitis (IC): Inflammation and mast cell activation Inflammation can release chemicals that disrupt the integrity of the bladders epithelial surface leading to mast cell activation and ultimately giving rise to pain and voiding dysfunction
2023 Nov 1;32:502-513
Individuals with PD have dramatically divergent microbial profiles compared to healthy controls (Romano et al., 2021)
